Medicinova (MNOV) Extends BARDA Contract to Develop MN-166 (

Medicinova (MNOV) Extends BARDA Contract to Develop MN-166 (ibudilast) as a Medical Countermeasure Against Chlorine Gas-induced Lung Injury

Medicinova (MNOV) Extends BARDA Contract to Develop MN-166 (ibudilast) as a Medical Countermeasure Against Chlorine Gas-induced Lung Injury
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

, Chemical Medical Countermeasures Program , Biomedical Advanced Research , Us Department Of Health , Human Services , Development Authority , Nasdaq , Nuclear Medical Countermeasures , Division Of Chemical , Department Of Health , Office Of The , Medicinova Inc , Division Of Research , Wall Street , Assistant Secretary , Repurposing Drugs , Chemical Threats , Nuclear Medical ,